Source: Journal of Neural Transmission. Unidades: FMRP, EERP, FORP
Subjects: DOENÇA DE PARKINSON, METABOLISMO, ÓXIDO NÍTRICO, DISCINESIAS, LÍQUIDO CEFALORRAQUIDIANO
ABNT
SANTOS-LOBATO, Bruno Lopes et al. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels. Journal of Neural Transmission, v. 129, n. 1, p. 55-63, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00702-021-02447-4. Acesso em: 22 ago. 2024.APA
Santos-Lobato, B. L., Bortolanza, M., Pinheiro, L. C., Batalhão, M. E., Pimentel, A. V., Cárnio, E. C., et al. (2022). Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels. Journal of Neural Transmission, 129( 1), 55-63. doi:10.1007/s00702-021-02447-4NLM
Santos-Lobato BL, Bortolanza M, Pinheiro LC, Batalhão ME, Pimentel AV, Cárnio EC, Del Bel EA, Tumas V. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels [Internet]. Journal of Neural Transmission. 2022 ; 129( 1): 55-63.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00702-021-02447-4Vancouver
Santos-Lobato BL, Bortolanza M, Pinheiro LC, Batalhão ME, Pimentel AV, Cárnio EC, Del Bel EA, Tumas V. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels [Internet]. Journal of Neural Transmission. 2022 ; 129( 1): 55-63.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00702-021-02447-4